Prasad Joni M, Gorkun Oleg V, Raghu Harini, Thornton Sherry, Mullins Eric S, Palumbo Joseph S, Ko Ya-Ping, Höök Magnus, David Tovo, Coughlin Shaun R, Degen Jay L, Flick Matthew J
Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH;
Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC;
Blood. 2015 Oct 22;126(17):2047-58. doi: 10.1182/blood-2015-04-639849. Epub 2015 Jul 30.
Fibrin(ogen) is central to hemostasis and thrombosis and also contributes to multiple physiologic and pathologic processes beyond coagulation. However, the precise contribution of soluble fibrinogen vs insoluble fibrin matrices to vascular integrity, tissue repair, inflammation, and disease has been undefined and unapproachable. To establish the means to distinguish fibrinogen- and fibrin-dependent processes in vivo, Fib(AEK) mice were generated that carry normal levels of circulating fibrinogen but lack the capacity for fibrin polymer formation due to a germ-line mutation in the Aα chain thrombin cleavage site. Homozygous Fib(AEK) mice developed to term and exhibited postnatal survival superior to that of fibrinogen-deficient mice. Unlike fibrinogen-deficient mice, platelet-rich plasma from Fib(AEK) mice supported normal platelet aggregation in vitro, highlighting that fibrinogen(AEK) retains the functional capacity to support interactions with platelets. Thrombin failed to release fibrinopeptide-A from fibrinogen(AEK) and failed to induce polymer formation with Fib(AEK) plasma or purified fibrinogen(AEK) in 37°C mixtures regardless of incubation time. Fib(AEK) mice displayed both an absence of fibrin polymer formation following liver injury, as assessed by electron microscopy, and a failure to generate stable occlusive thrombi following FeCl3 injury of carotid arteries. Fib(AEK) mice exhibited a profound impediment in Staphylococcus aureus clearance following intraperitoneal infection similar to fibrinogen-deficient mice, yet Fib(AEK) mice displayed a significant infection dose-dependent survival advantage over fibrinogen-deficient mice following peritonitis challenge. Collectively, these findings establish for the first time that fibrin polymer is the molecular form critical for antimicrobial mechanisms while simultaneously highlighting biologically meaningful contributions and functions of the soluble molecule.
纤维蛋白(原)在止血和血栓形成过程中起核心作用,并且在凝血以外的多种生理和病理过程中也发挥作用。然而,可溶性纤维蛋白原与不溶性纤维蛋白基质对血管完整性、组织修复、炎症和疾病的确切贡献尚未明确且难以确定。为了建立在体内区分纤维蛋白原依赖性和纤维蛋白依赖性过程的方法,研究人员培育出了Fib(AEK)小鼠,这些小鼠循环纤维蛋白原水平正常,但由于Aα链凝血酶切割位点的种系突变而缺乏纤维蛋白聚合物形成能力。纯合子Fib(AEK)小鼠发育至足月,并且出生后的存活率高于纤维蛋白原缺陷小鼠。与纤维蛋白原缺陷小鼠不同,Fib(AEK)小鼠的富含血小板血浆在体外支持正常的血小板聚集,这突出表明纤维蛋白原(AEK)保留了支持与血小板相互作用的功能能力。凝血酶无法从纤维蛋白原(AEK)中释放纤维蛋白肽 - A,并且在37°C的混合物中,无论孵育时间多长,都无法诱导Fib(AEK)血浆或纯化的纤维蛋白原(AEK)形成聚合物。通过电子显微镜评估,Fib(AEK)小鼠在肝损伤后既没有形成纤维蛋白聚合物,在颈动脉受到FeCl3损伤后也未能形成稳定的闭塞性血栓。Fib(AEK)小鼠在腹腔感染后清除金黄色葡萄球菌的能力受到严重阻碍,这与纤维蛋白原缺陷小鼠相似,然而在腹膜炎激发后,Fib(AEK)小鼠在感染剂量依赖性方面比纤维蛋白原缺陷小鼠具有显著的存活优势。总体而言,这些发现首次证实纤维蛋白聚合物是抗菌机制的关键分子形式,同时突出了可溶性分子具有生物学意义的贡献和功能。